Search Clinical Trials
598,375 trials
ID
Status
Phase
Title
Sponsor
NCT07766499
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Assess the Efficacy and Safety of THB335 in Adult Participants With Chronic Spontaneous Urticaria (CSU)Calixis Inc.Not Yet RecruitingPhase 2
NCT07766499Not Yet Recruiting
Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multice...Calixis Inc.
NCT07766538
Feasibility and Uptake of Low-Dose CT Lung Cancer Screening in KuwaitKuwait Foundation for the Advancement of SciencesNot Yet RecruitingNot Applicable
NCT07766538Not Yet Recruiting
Not Applicable
Feasibility and Uptake of Low-Dose CT Lung Cancer Screening in KuwaitKuwait Foundation for the...
NCT07766369
A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy ParticipantsEisai Inc.Not Yet RecruitingPhase 1
NCT07766369Not Yet Recruiting
Phase 1
A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy Participa...Eisai Inc.
NCT07766291
Mapping the Neural Circuits of Depression and Anxiety Using Personalized, Accelerated TMS and Deep PhenotypingNational University Hospital, SingaporeNot Yet RecruitingNot Applicable
NCT07766291Not Yet Recruiting
Not Applicable
Mapping the Neural Circuits of Depression and Anxiety Using Personalized, Accele...National University Hospi...
NCT07765940
Safety and Preliminary Diagnostic Performance of [⁶⁴Cu]Cu-RAX301 in Prostate CancerRadAlliance Therapeutics, IncNot Yet RecruitingPhase 1
NCT07765940Not Yet Recruiting
Phase 1
Safety and Preliminary Diagnostic Performance of [⁶⁴Cu]Cu-RAX301 in Prostate Can...RadAlliance Therapeutics,...
NCT07765628
A Phase 2 Study of HS-20118 to Evaluate the Efficacy and Safety in Participant With Moderate-to-Severe Plaque PsoriasisJiangsu Hansoh Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 2
NCT07765628Not Yet Recruiting
Phase 2
A Phase 2 Study of HS-20118 to Evaluate the Efficacy and Safety in Participant W...Jiangsu Hansoh Pharmaceut...
NCT07765966
Phase 1 Dose Escalation Study of RXIM002 in Autoimmune CytopeniasRiboX Therapeutics Ltd.Not Yet RecruitingPhase 1
NCT07765966Not Yet Recruiting
Phase 1
Phase 1 Dose Escalation Study of RXIM002 in Autoimmune CytopeniasRiboX Therapeutics Ltd.
NCT07764835
Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)AstraZenecaNot Yet Recruiting
NCT07764835Not Yet Recruiting
—
Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patie...AstraZeneca
NCT07766486
Prospective Study on the Role of Radical Prostatectomy in Oligo-metastatic Hormone-sensitive Prostate Cancer in Patients on Androgen Deprivation TherapyFondazione del Piemonte per l'OncologiaActive Not RecruitingNot Applicable
NCT07766486Active Not Recruiting
Not Applicable
Prospective Study on the Role of Radical Prostatectomy in Oligo-metastatic Hormo...Fondazione del Piemonte p...
NCT07764796
Mobile Health Patient Navigation for the Improvement of Screening and the Early Detection of Breast Cancer in Women Accessing Primary Care Clinics in KenyaEmory UniversityRecruitingNot Applicable
NCT07764796Recruiting
Not Applicable
Mobile Health Patient Navigation for the Improvement of Screening and the Early...Emory University
NCT07766044
A One-year Follow-up of Incisional Hernia Formation Between Device Assisted and Manual Laparotomy ClosureLund UniversityRecruitingNot Applicable
NCT07766044Recruiting
Not Applicable
A One-year Follow-up of Incisional Hernia Formation Between Device Assisted and...Lund University
NCT07764978
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCTAstraZenecaRecruitingPhase 3
NCT07764978Recruiting
Phase 3
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCTAstraZeneca
NCT07765316
Targeting Pathogenic Myelopoiesis in Pancreatic CancerIRCCS San RaffaeleNot Yet Recruiting
NCT07765316Not Yet Recruiting
—
Targeting Pathogenic Myelopoiesis in Pancreatic CancerIRCCS San Raffaele
NCT07764744
Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic VariantsM.D. Anderson Cancer CenterNot Yet RecruitingNot Applicable
NCT07764744Not Yet Recruiting
Not Applicable
Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals Wit...M.D. Anderson Cancer Cent...
NCT07765992
AI-Based Oxytocin-Stimulated Smart Lactation Support VestSelcuk UniversityNot Yet RecruitingNot Applicable
NCT07765992Not Yet Recruiting
Not Applicable
AI-Based Oxytocin-Stimulated Smart Lactation Support VestSelcuk University
NCT07766265
NEST: A Group Intervention for Parents With Complex PTSDSt.Gallen University of Applied SciencesNot Yet RecruitingNot Applicable
NCT07766265Not Yet Recruiting
Not Applicable
NEST: A Group Intervention for Parents With Complex PTSDSt.Gallen University of A...
NCT07765433
Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract CancerECOG-ACRIN Cancer Research GroupNot Yet RecruitingPhase 2
NCT07765433Not Yet Recruiting
Phase 2
Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared...ECOG-ACRIN Cancer Researc...
NCT07765160
Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese ParticipantsInnovent Biologics (Suzhou) Co. Ltd.Not Yet RecruitingPhase 1
NCT07765160Not Yet Recruiting
Phase 1
Clinical Trials of IBI3040 in Healthy Participants and Overweight or Obese Parti...Innovent Biologics (Suzho...
Result Breakdown
Not yet recruiting16 (80%)
Recruiting3 (15%)
Active, not recruiting1 (5%)
not_applicable9 (45%)
Phase 14 (20%)
Phase 23 (15%)
Not Specified3 (15%)
Phase 31 (5%)